LINES DESIGN

Trademark usage description

pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism, namely, renal diseases, Read More

Vienna Information

26 . 3 . 1

One triangleUn triangle

26 . 3 . 7

Triangular figures with one or more truncated or rounded anglesFigures triangulaires à un ou plusieurs angles coupés ou arrondis

26 . 3 . 12

Triangles containing one or more other geometrical figures -- Note: Including triangles containing bent or straight lines.Triangles contenant une ou plusieurs autres figures géométriques -- Note: Y compris les triangles contenant des lignes courbées ou droites.

26 . 3 . 26

Triangles with cutout areasTriangles avec des zones découpées

26 . 4 . 4

Other irregular parallelograms, trapezia and quadrilaterals, quadrilaterals containing one or more rounded cornersAutres parallélogrammes, trapèzes et quadrilatères irréguliers, quadrilatères avec un ou plusieurs coins arrondis

26 . 4 . 5

One quadrilateralUn quadrilatère

26 . 4 . 11

Quadrilaterals containing one or more triangles or lines forming an angleQuadrilatères contenant un ou plusieurs triangles ou des lignes formant un angle

26 . 3 . 23

Lines or bands forming an angle -- Note: Including chevrons and arrowheads formed by lines or bands.Lignes ou bandes formant un angle -- Note: Y compris les chevrons et les pointes de flèches formées par des lignes ou des bandes.

26 . 11 . 3

More than two lines or two bandsPlus de deux lignes ou de deux bandes

26 . 11 . 6

Thick lines, bandsLignes épaisses, bandes

25 . 7 . 20

Surfaces or backgrounds covered with lines or bandsSurfaces ou fonds couverts de lignes ou de bandes

25 . 7 . 23

Surfaces or backgrounds covered with lines or bands in zigzag or chevron patternSurfaces ou fonds couverts de lignes ou de bandes en dents de scie ou en chevrons

29 . 1 . 4

BlueBleu

29 . 1 . 5

VioletViolet

29 . 1 . 3

GreenVert

Classification Information

Class [005]
Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism, namely, renal diseases, liver diseases, pancreas diseases, digestive system disorders, gastrointestinal diseases and disorders, obesity; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the blood and blood forming organs, namely, vascular diseases, hematology, blood disorders; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders, musculoskeletal diseases and disorders, central nervous system diseases and disorders, peripheral nervous system diseases and disorders; pharmaceutical preparations for the prevention and treatment of genitourinary diseases, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues, namely, rashes, sores, psoriasis, eczema; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders, namely, anti-inflammatories; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections, namely, antibiotics, anti-infectives, antivirals; pharmaceutical preparations for the prevention and treatment of oncological diseases; pharmaceutical preparations for the prevention and treatment of auto-immune diseases and disorders; cell based immune therapeutics for treatment of cancer; cell based immune therapeutics for treatment of immunological diseases, namely, autoimmune diseases and disorders; cell based immune therapeutics for treatment of infectious diseases, namely viral infections.

Classification kind code

Mark Details

Serial Number

2322260

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 256 on 18^th Feb 2025	Notification of Possible Opposition Sent
Submitted for opposition 257 on 18^th Apr 2024	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 17^th Apr 2024	Created
Submitted for opposition 31 on 17^th Apr 2024	Formalized
Submitted for opposition 228 on 7^th Mar 2024	International Registration
Submitted for opposition 30 on 7^th Mar 2024	Filed